Research grants

Donate

Code	Title	Period	Principal Investigator at the Institute of Oncology
LEA-EBAM-	European Laboratory of Pulsed Electric Fields Applications in Biology and Medicine	19. 8. 2024 - to present	acad. prof. dr. Gregor Serša
BI-US-22-24-070	Bridging the gap between three-dimensional biomimetic vascular models and in vivo tumor vasculature	1. 7. 2022 - 30. 6. 2024	dr. Boštjan Markelc
BI-US-22-24-026	Factors affecting combined electrochemotherapy with immunogene therapy of cancer	1. 7. 2022 - 30. 6. 2024	Acad. Prof. Serša Gregor
J3-3084	Inducible programming of CAR T cell intrinsic properties for cancer immunotherapy	1. 9. 2021 - 31. 8. 2024	dr. Anže Smole (National Institute of Biology) / prof. dr. Maja Čemažar (Institute of Oncology Ljubljana)
J3-3083	Vascularization and vascular effects as predictive factors for local ablative techniques	1. 9. 2021 - 31. 8. 2024	acad. prof. dr. Serša Gregor
Z3-2651	Electrochemotherapy as in situ vaccination therapy	1. 9. 2020 - 31. 8. 2023	dr. Katja Uršič Valentinuzzi
J3-2528	Immuno gene electrotransfer of IL-12 and IL-2 in immunologically cold/hot tumors	1. 9. 2020 - 31. 8. 2023	prof. dr. Maja Čemažar
J4-2594	The amniotic membrane as a novel multimodal therapy for bacterial cystitis and bladder cancer: unravelling its antimicrobial, immunomodulatory and anticancer activity	1. 9. 2020 - 31. 8. 2023	prof. dr. Mateja Erdani Kreft (Faculty of Medicine)/ prof. dr. Maja Čemažar (Institute of Oncology Ljubljana)
J4-2546	Monitoring of the clinical and immune response to improve the outcome of combined electrochemotherapy and IL-12 gene therapy in dogs with spontaneous peripheral tumours	1. 9. 2020 - 31. 8. 2023	prof. dr. Nataša Tozon (Veterinary Faculty)/prof. dr. Maja Čemažar (Institute of Oncology Ljubljana)
J3-2529	Role of endothelium in tumor response to radiotherapy	1. 9. 2020 - 31. 8. 2023	dr. Boštjan Markelc
Z3-1873	A novel vascular targeted approach based on gene therapy silencing two independent signaling pathways in combination with radiotherapy	1. 7. 2019 - 30. 6. 2024	dr. Monika Savarin
Z3-1871	Combination of electrochemotherapy with poly (adenosin diphosphate-ribose) polymerase inhibitor in treatment of breast cancer	1. 7. 2019 - 30. 6. 2021	dr. Maša Bošnjak
PROTEUS-	In vivo gene therapy targeting of skin-resident immune cells	1. 1. 2019 - 30. 9. 2021	dr. Urška Kamenšek
BI-US-18-20-027	Radiotherapy induced expression of DNA sensors and cytokines in tumor cells	1. 10. 2018 - 30. 9. 2020	prof. dr. Maja Čemažar
J3-9269	Clinical pharmacological approach to optimization of therapeutic concentration of bleomycin treatment with electrochemotherapy	1. 7. 2018 - 30. 6. 2021	acad. prof. dr. Serša Gregor
J2-9225	Non-invasive technique for Cell Membrane Permeabilization using pulsed electromagnetic fields	1. 7. 2018 - 30. 6. 2021	prof. dr. Damijan Miklavčič (Faculty of Electrical Engineering/ acad. prof. dr. Gregor Serša Institute of Oncology Ljubljana
/	Smartgene.Si	1. 7. 2018 - 30. 9. 2021	acad. prof. dr. Gregor Serša
Z3-8204	Involvement of cytosolic DNA sensors in irradiation induced bystander and abscopal effect	1. 4. 2018 - 31. 3. 2020	dr. Tanja Jesenko
BI-AT-18-19-003	Cancer stem cell (CSC)-associated exosomes as regulators of tumor radiation response	1. 1. 2018 - 31. 12. 2019	prof. dr. Maja Čemažar
J4-8227	Cathepsin X inhibitors impair the resistence of tumor cells to antiprotease therapy	1. 5. 2017 - 30. 4. 2020	prof. dr. Kos Janko (Univerza v Ljubljani, Fakulteta za farmacijo/IJS)/ acad. prof. dr. Gregor Serša (Onkološki inštitut)
J1-8140	Endocrine disrupting and genotoxic potential of protein kinase inhibitors: relevance for environmental hazard	1. 5. 2017 - 30. 4. 2021	prof. dr. Filipič Metka (National Institute of Biology) / prof. dr. Maja Čemažar (Institute of Oncology Ljubljana)
J3-8202	Time-lapse intra-vital imaging of immune response after electrochemotherapy induced in situ vaccination and interleukin-12 gene therapy boost	1. 4. 2017 - 30. 4. 2021	prof. dr. Maja Čemažar
N3-0059	Plasma-assisted wound treatment and topical introduction of molecules	1. 1. 2017 - 31. 12. 2020	dr. Uroš Cvelbar (Jozef Stefan Institute)/acad. prof. dr. Serša Gregor (Institute of Oncology Ljubljana)
L2-7550	Electrospun nanofibrous materials for solid state drug delivery system	1. 3. 2016 - 28. 2. 2019	prof. dr. Igor Emri /acad. prof. dr. Gregor Serša (Institute of Oncology Ljubljana)
J3-7460	Irradiation dose modifying factor of squamous cell carcinoma of the oropharynx infected by human papillomavirus: an in vitro and in vivo study in laboratory mouse tumor model	1. 1. 2016 - 31. 12. 2018	prof. dr. Strojan Primož/Institute of Oncology Ljubljana
Completed international projects	DNA-specific pattern recognition receptor activation following DNA electroporation	1. 7. 2015 - 31. 12. 2022	NIH-
P3-0003	Development and evaluation of new approaches to cancer treatment	1. 7. 2004 - 31. 12. 2027	Acad. Prof. Serša Gregor

SRA – Slovenian Research Agency (https://www.arrs.gov.si)

NIH – National Institute of Health (https://www.nih.gov/)

LEA EBAM - The European Associated Laboratory (LEA) entitled “Pulsed Electric Fields Applications in Biology and Medicine (http://lea-ebam.cnrs.fr/)

Name	Purpose	Lifetime
_pk_id	Counting web site visitors.	13 months
_pk_ref	Tracking from which sites users come to our web pages.	6 months
_pk_ses	Counting web site visits.	30 minutes
_ga	Used to distinguish users.	2 years
_ga_--container-id--	Persists session state.	2 years

Department of Experimental Oncology